About us
Leveraging cutting-edge
scientific research and technology
Who we are
ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders.
Our mission
We are committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space.
Our approach
By pooling expertise, best practices, and resources across our entire portfolio, we mitigate risk and responsibly accelerate the development of impactful and evidence-based treatments.
Focus on
Mental health
ATAI is supporting the revival of treatments with prior evidence in humans, such as psilocybin and ketamine, in fighting mental health disorders
Focus on
Longevity
ATAI is looking into different ways to increase the human healthspan and reverse aging
Focus on
AI & Big Data
ATAI is leveraging the potential of artificial intelligence (AI) and big data analytics to optimize and accelerate the drug development process
Our Strategy
The evolution of biotech
Science fiction becomes reality
Technology has kicked off a new era of biotech, outpacing Moore’s law. We acquire compounds that can benefit from leveraging this technological advancement by developing them on our platform. Compounds that we acquire are in general at an early stage of the drug development process.
We envision to put an end to mental health disorders. To deliver on this vision, we focus on developing solutions for people that suffer from a real unmet medical need – starting with the 320mn patients that suffer from depression.
We believe that small teams are more effective and efficient. Our decentralized and lean setup allows us to constantly spread learning, expertise and best practices across the ATAI platform enabling operational excellence and entrepreneurship.
World-class business and science experts ensure successful execution of acquisitions and pre-clinical & clinical studies in record speed.
Our Team
Vast experience
and great access to deal flow
Our Companies
A portfolio of innovation
Accelerating progress in life sciences
COMPASS Pathways
develops psilocybin therapy for patients with treatment-resistant depression.
compasspathways.com
Perception Neuroscience
develops arketamine therapy for patients with neuropsychiatric diseases.
perceptionneuroscience.com
Innoplexus
leverages the power of AI and big data analytics for a variety of applications in life sciences, like drug development.
innoplexus.com
COMPASS Pathways
develops psilocybin therapy for patients with treatment-resistant depression.
compasspathways.com
Perception Neuroscience
develops arketamine therapy for patients with neuropsychiatric diseases.
perceptionneuroscience.com
Innoplexus
leverages the power of AI and big data analytics for a variety of applications in life sciences, like drug development.
innoplexus.com
Juvenescence
invests in companies with therapies for aging and age-related diseases.
juvenescence.ltd
Insights
Learn about cutting-edge science
and gain life-enhancing insights
Follow us on Twitter and read our blog
Careers
Work with us
to improve the lives of millions of people
WE ARE HIRING! Learn about career opportunities at ATAI and see open jobs across our platform companies.
Let’s stay in touch
Sign up to our newsletter to receive updates on our progress:
75%
A biography (or simply bio) is a detailed description of a person’s life. It involves more than just the basic facts like education, work, relationships.
43%
A biography (or simply bio) is a detailed description of a person’s life. It involves more than just the basic facts like education, work, relationships.
87%
A biography (or simply bio) is a detailed description of a person’s life. It involves more than just the basic facts like education, work, relationships.